A carregar...
A single, clinically relevant dose of the GABA(B) agonist baclofen impairs visuomotor learning
The GABA(B) agonist baclofen is taken daily as a treatment for spasticity by millions of stroke, brain injury and multiple sclerosis patients, many of whom are also undergoing motor rehabilitation. However, decreases in GABA are suggested to be a key feature of human motor learning, which raises que...
Na minha lista:
| Publicado no: | J Physiol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7611062/ https://ncbi.nlm.nih.gov/pubmed/33085094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1113/JP280378 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|